{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:01:53Z","timestamp":1787911313309,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302826"],"award-info":[{"award-number":["81302826"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473280"],"award-info":[{"award-number":["81473280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program for Key Laboratory of Liaoning Province","award":["LZ2015027"],"award-info":[{"award-number":["LZ2015027"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejphar.2018.02.002","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T18:15:56Z","timestamp":1518027356000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity"],"prefix":"10.1016","volume":"824","author":[{"given":"Yulong","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenqing","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.02.002_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.002_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14035","article-title":"p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice","author":"Chen","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1124\/dmd.113.056549","article-title":"Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice: potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins","volume":"42","author":"Chen","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2018.02.002_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/toxsci\/kfp094","article-title":"Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice","volume":"110","author":"Cui","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2018.02.002_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fphar.2017.00162","article-title":"Targeting bile acid receptors: discovery of a potent and selective farnesoid X receptor agonist as a new lead in the pharmacological approach to liver diseases","volume":"8","author":"Festa","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury - what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/dmd.113.054189","article-title":"The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity","volume":"42","author":"Garzel","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2018.02.002_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfw098","article-title":"Pyrazinamide induced rat cholestatic liver injury through inhibition of FXR regulatory effect on bile acid synthesis and transport","volume":"152","author":"Guo","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2018.02.002_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000445268","article-title":"Farnesoid X receptor agonists and other bile acid signaling strategies for treatment of liver disease","volume":"34","author":"Halilbasic","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.ejphar.2018.02.002_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2017.06.009","article-title":"The synthesis and antitumor activity of lithocholic acid and its derivatives","volume":"125","author":"He","year":"2017","journal-title":"Steroids"},{"key":"10.1016\/j.ejphar.2018.02.002_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity","volume":"36","author":"Hofmann","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejphar.2018.02.002_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.phrs.2012.04.003","article-title":"Kavalactones and the endocannabinoid system: the plant-derived yangonin is a novel CB(1) receptor ligand","volume":"66","author":"Ligresti","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2018.02.002_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/mp060133c","article-title":"Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors","volume":"4","author":"Marschall","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2018.02.002_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1039\/C5FO00082C","article-title":"Protective effects of alisol B 23-acetate from edible botanical Rhizoma alismatis against carbon tetrachloride-induced hepatotoxicity in mice","volume":"6","author":"Meng","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2018.02.002_bib16","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1007\/s11095-015-1727-x","article-title":"Protective effects of alisol B 23-acetate via farnesoid X receptor-mediated regulation of transporters and enzymes in estrogen-induced cholestatic liver injury in mice","volume":"32","author":"Meng","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2018.02.002_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2015.01.020","article-title":"Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis","volume":"283","author":"Meng","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/dmd.109.029306","article-title":"Intestinal detoxification limits the activation of hepatic pregnane X receptor by lithocholic acid","volume":"38","author":"Owen","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2018.02.002_bib19","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.117.077420","article-title":"Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfation","author":"Sharanek","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2018.02.002_bib20","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/hep.27171","article-title":"Transcriptional dynamics of bile salt export pump during pregnancy: mechanisms and implications in intrahepatic cholestasis of pregnancy","volume":"60","author":"Song","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.002_bib21","article-title":"beta-catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis","author":"Thompson","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.002_bib22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10354-008-0592-1","article-title":"Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases","volume":"158","author":"Trauner","year":"2008","journal-title":"Wien. Med. Wochenschr."},{"key":"10.1016\/j.ejphar.2018.02.002_bib23","doi-asserted-by":"crossref","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2018.02.002_bib24","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s13197-013-1047-2","article-title":"Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents","volume":"52","author":"Wang","year":"2015","journal-title":"J. Food Sci. Technol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib25","article-title":"IL-1 receptor like 1 protects against alcoholic liver injury by limiting NF-kappaB activation in hepatic macrophages","author":"Wang","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib26","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.002_bib27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2012.08.023","article-title":"Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury","volume":"200","author":"Wang","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2018.02.002_bib28","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1124\/mol.107.042499","article-title":"Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1\/2-dependent nuclear factor erythroid 2-related factor 2 activation","volume":"73","author":"Wruck","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib29","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/hep.28712","article-title":"Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice","volume":"64","author":"Xu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.002_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bph.13729","article-title":"Schisandrol B protects against cholestatic liver injury through pregnane X receptors","volume":"174","author":"Zeng","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/dmd.115.066969","article-title":"Hepatoprotective effects of Schisandra sphenanthera extract against lithocholic acid-induced cholestasis in male mice are associated with activation of the pregnane X receptor pathway and promotion of liver regeneration","volume":"44","author":"Zeng","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2018.02.002_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.taap.2016.11.006","article-title":"Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation","volume":"314","author":"Zhang","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jep.2015.01.047","article-title":"Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor","volume":"164","author":"Zhang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2018.02.002_bib34","doi-asserted-by":"crossref","DOI":"10.7555\/JBR.31.20160160","article-title":"Kavalactone yangonin induces autophagy and sensitizes bladder cancer cells to flavokawain A and docetaxel via inhibition of the mTOR pathway","author":"Zhongbo","year":"2017","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.ejphar.2018.02.002_bib35","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pharmthera.2010.03.005","article-title":"Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity","volume":"126","author":"Zollner","year":"2010","journal-title":"Pharmacol. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T01:23:28Z","timestamp":1660440208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":35,"alternative-id":["S0014299918300748"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.002","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}